Friday April 3, 2020

Cystic Fibrosis drugs to cost €400 million over ten years

The HSE and the drug’s maker Vertex have reached a deal in principle on providing the drugs Orkambi and Kalydeco to CF patients

16th April, 2017

The deal to provide life-changing drugs to cystic fibrosis sufferers will cost the state close to €400 million over ten years.

The HSE and the drug’s maker Vertex have reached a deal in principle on providing the drugs Orkambi and Kalydeco to CF patients, but the final terms and conditions are still being worked out.

The final cost will be approved by ministers at a cabinet meeting before the end of the month,...

Subscribe from just €1 for the first month!

Exclusive offers:

All Digital Access + eReader

Trial

€1

Unlimited Access for 1 Month

Then €19.99 a month after the offer period.

Get basic
*New subscribers only
You can cancel any time.

Annual

€200

€149 For the 1st Year

Unlimited Access for 1 Year

You can cancel any time.

Quarterly

€55

€42

90 Day Pass

You can cancel any time.

Team Pass

Get a Business Account for you and your team

Share this post

Related Stories

The passports are currently in development by researchers in Germany

Susan Mitchell | 14 hours ago

The country is cited as the model for Ireland’s approach to the coronavirus but we are not conducting or processing nearly enough tests

Domhnall Heron | 18 hours ago

Some countries’ approach to Covid-19 appear ageist in the extreme, but Ireland needs to take a more compassionate stance

Diarmuid O’Shea | 1 day ago